Could a Twice-Yearly injection stop heart attacks?
NCT ID NCT03705234
Summary
This large study is testing whether a new cholesterol-lowering injection called inclisiran can safely reduce the risk of future heart attacks, strokes, and related heart problems in people who already have heart disease. Over 16,000 participants received either the injection or a placebo (dummy shot) every six months for about five years. The goal is to see if this treatment helps people with existing heart conditions live longer, healthier lives by better controlling their cholesterol.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CTSU, University of Oxford
Oxford, Oxfordshire, OX3 7LF, United Kingdom
-
TIMI Study Group
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.